The latest on artificial intelligence transforming medicine

Contract Pharma’s Read on AI R&D Suggests Early Discovery Is Becoming a Workflow Engineering Problem

A new analysis of AI in early drug development argues that the field’s next phase will be decided by workflow design, not by model hype alone. The implication for biopharma is that durable advantage may come from integrating AI into experimental loops rather than treating it as a separate innovation layer.